How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

WI

NASDAQ:WINT
Get a brief AI stock analysisSaves ~ 15 minutes of your time

WI

Windtree Therapeutics IncNASDAQ WINT Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is WINT undervalued compared to its fair value?

The fair value of WINT stock is hidden USD. Relative to the market price of 3.56 USD Windtree Therapeutics Inc is hidden.

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care ma...[More about valuation]

Windtree Therapeutics Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.002 $B

Price:

3.56 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.86

FINANCIALS

Windtree Therapeutics financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0047 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0044 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.036 B
0.0075 B

Financial Position Analysis

Assets

0.036 B
Current Assets
0.0089 B
Total non-current assets
0.027 B

Total current liabilities
0.0037 B
Total non-current liabilities
0.025 B

Cash Flow Statement

-0.0041 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0039 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Windtree Therapeutics fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is WINT attractive for investment based on fundamental analysis?

WINT stock rating is hidden. Windtree Therapeutics is a hidden by Eyestock methodology.

Get WINT Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

WINT analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for WINT to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Windtree Therapeutics Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Windtree Therapeutics Inc dividends

WINT dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About WINT stock

About the company Windtree Therapeutics Inc

Market cap $B

0.002

Dividend yield

Shares outstanding

0.772202 B

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. The company is headquartered in Warrington, Pennsylvania and currently employs 33 full-time employees. The Company’s development programs are primarily focused on the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. Its Cardiovascular Program’s products candidates include Istaroxime, Oral SERCA2a Activators and Rostafuroxin. Its Pulmonary Program’s product candidates include Lyophilized KL4 Surfactant and AEROSURF (aerosolized KL4 surfactant based on ADS technology). The Company’s lead product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure (AHF) with a potentially differentiated safety profile from existing treatments. Istaroxime demonstrated significant improvement in both diastolic and systolic aspects of cardiac function and is under phase II clinical trials.

WINT profile

  • Ticker

    WINT

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    09 August 1995

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    33

  • City

    Warrington

  • Address

    2600 Kelly Rd Ste 100

  • Cusip

    97382D402